B Astruc

865 total citations
21 papers, 689 citations indexed

About

B Astruc is a scholar working on Nutrition and Dietetics, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, B Astruc has authored 21 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Nutrition and Dietetics, 4 papers in Epidemiology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in B Astruc's work include Clinical Nutrition and Gastroenterology (4 papers), Influenza Virus Research Studies (2 papers) and Respiratory viral infections research (2 papers). B Astruc is often cited by papers focused on Clinical Nutrition and Gastroenterology (4 papers), Influenza Virus Research Studies (2 papers) and Respiratory viral infections research (2 papers). B Astruc collaborates with scholars based in France, Switzerland and Belgium. B Astruc's co-authors include Gregory S. Cameron, Jerry R. Greenfield, Julie Satterwhite, John P. Mayer, Julia M. Keogh, Jeffrey W. Miller, Elana Henning, David J. Lomas, I. Sadaf Farooqi and Søren Brage and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Journal of Hepatology.

In The Last Decade

B Astruc

20 papers receiving 669 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B Astruc France 9 267 208 154 142 141 21 689
Cameron W. Lush Canada 13 206 0.8× 77 0.4× 137 0.9× 268 1.9× 255 1.8× 16 864
Micaela Bernareggi Italy 13 230 0.9× 61 0.3× 35 0.2× 151 1.1× 457 3.2× 24 814
Taku Tsunekawa Japan 14 107 0.4× 58 0.3× 147 1.0× 145 1.0× 193 1.4× 34 839
O. Wisén Sweden 14 125 0.5× 111 0.5× 148 1.0× 119 0.8× 175 1.2× 28 720
Daniela Romualdi Italy 25 144 0.5× 54 0.3× 53 0.3× 319 2.2× 106 0.8× 53 1.4k
Eva W. Iepsen Denmark 13 183 0.7× 63 0.3× 81 0.5× 342 2.4× 283 2.0× 16 916
Adele Kennedy United Kingdom 13 350 1.3× 166 0.8× 278 1.8× 657 4.6× 298 2.1× 22 1.2k
Eugenio Arteaga Chile 18 77 0.3× 58 0.3× 56 0.4× 492 3.5× 73 0.5× 73 868
Petra Steindl Austria 13 57 0.2× 320 1.5× 208 1.4× 28 0.2× 75 0.5× 24 849
Jacob T. Mey United States 16 55 0.2× 71 0.3× 161 1.0× 170 1.2× 412 2.9× 33 904

Countries citing papers authored by B Astruc

Since Specialization
Citations

This map shows the geographic impact of B Astruc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Astruc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Astruc more than expected).

Fields of papers citing papers by B Astruc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Astruc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Astruc. The network helps show where B Astruc may publish in the future.

Co-authorship network of co-authors of B Astruc

This figure shows the co-authorship network connecting the top 25 collaborators of B Astruc. A scholar is included among the top collaborators of B Astruc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Astruc. B Astruc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McClure, Matthew W., Elina Berliba, Tengiz Tsertsvadze, et al.. (2018). Safety, tolerability, and pharmacokinetics of AL-335 in healthy volunteers and hepatitis C virus-infected subjects. PLoS ONE. 13(10). e0204974–e0204974. 8 indexed citations
2.
Sesay, Sanie, Jerzy Brzostek, Ingo Meyer, et al.. (2017). Safety, immunogenicity, and lot-to-lot consistency of a split-virion quadrivalent influenza vaccine in younger and older adults: A phase III randomized, double-blind clinical trial. Human Vaccines & Immunotherapeutics. 14(3). 596–608. 17 indexed citations
3.
Rouzier, Roman, et al.. (2017). Immunogenicity and safety of the Southern Hemisphere 2015 formulation of Vaxigrip®. Human Vaccines & Immunotherapeutics. 13(11). 2674–2677. 4 indexed citations
4.
Astruc, B, Helen Jenkins, & Richard O. Jenkins. (2017). Effect of Therapeutic and Supratherapeutic Doses of Vonoprazan on the QT/QTc Interval in a Phase I Randomized Study in Healthy Subjects. Clinical and Translational Science. 10(3). 208–216. 8 indexed citations
5.
Kaufmann, Priska, et al.. (2016). Absolute oral bioavailability of selexipag, a novel oral prostacyclin IP receptor agonist. European Journal of Clinical Pharmacology. 73(2). 151–156. 19 indexed citations
6.
Astruc, B, Shikiko Watanabe, Adwoa Parker, & R. Hulhoven. (2016). AB0301 Comparison of The Bioavailability of A Single Dose of Certolizumab Pegol Injected either by A Pre-Filled Syringe or by An Auto-Injection Device. Annals of the Rheumatic Diseases. 75. 1003–1003. 2 indexed citations
7.
Baldoni, Daniela, Shirin Bruderer, Andreas Krause, et al.. (2014). A New Reversible and Potent P2Y12 Receptor Antagonist (ACT-246475): Tolerability, Pharmacokinetics, and Pharmacodynamics in a First-in-Man Trial. Clinical Drug Investigation. 34(11). 807–818. 34 indexed citations
8.
Marquet, Anne, et al.. (2012). The Effect of Safinamide, a Novel Drug for Parkinson's Disease, on Pressor Response to Oral Tyramine: A Randomized, Double-Blind, Clinical Trial. Clinical Pharmacology & Therapeutics. 92(4). 450–7. 30 indexed citations
9.
Guyader, D., Pavel Bogomolov, Zhanna Kobalava, et al.. (2011). 1209 IMO-2125 PLUS RIBAVIRIN GIVES SUBSTANTIAL FIRST-DOSE VIRAL LOAD REDUCTIONS, CUMULATIVE ANTI-VIRAL EFFECT, IS WELL TOLERATED IN NAIVE GENOTYPE1 HCV PATIENTS: A PHASE 1 TRIAL. Journal of Hepatology. 54. S478–S478. 4 indexed citations
10.
Greenfield, Jerry R., Jeffrey W. Miller, Julia M. Keogh, et al.. (2008). Modulation of Blood Pressure by Central Melanocortinergic Pathways. New England Journal of Medicine. 360(1). 44–52. 360 indexed citations
11.
Rosillon, Dominique, et al.. (2008). Effect of brivaracetam on cardiac repolarisation – a thorough QT study. Current Medical Research and Opinion. 24(8). 2327–2337. 30 indexed citations
12.
13.
Parks, Virginia, et al.. (2006). PIII-39Safety, tolerability and pharmacokinetics (PK) of multiple doses of lecozotan, a novel 5HT1A antagonist, in healthy elderly subjects. Clinical Pharmacology & Therapeutics. 79(2). P68–P68. 1 indexed citations
14.
Astruc, B, et al.. (2005). Steady‐state pharmacokinetics and pharmacodynamics of CHF3381, a novel antineuropathic pain agent, in healthy subjects. British Journal of Clinical Pharmacology. 59(4). 405–414. 3 indexed citations
15.
Astruc, B, Peter Marbach, Hakim Bouterfa, et al.. (2005). Long‐Acting Octreotide and Prolonged‐Release Lanreotide Formulations Have Different Pharmacokinetic Profiles. The Journal of Clinical Pharmacology. 45(7). 836–844. 102 indexed citations
16.
Giuliano, F., et al.. (2005). 537Tadalafil shows no clinically significant haemodynamic interaction with alfuzosin. European Urology Supplements. 4(3). 137–137. 2 indexed citations
17.
Astruc, B, P Petit, & M. Abbar. (1999). Overdose with sustained-release lithium preparations. European Psychiatry. 14(3). 172–174. 8 indexed citations
18.
Solassol, C, et al.. (1980). Complete nutrients mixtures with lipids for total parenteral nutrition in cancer patients.. PubMed. 498. 151–4. 4 indexed citations
19.
Joyeux, H, B Astruc, & C Solassol. (1976). Total parenteral nutrition by portal vein in canine pregnancy [proceedings].. PubMed. 466. 105–105. 1 indexed citations
20.
Astruc, B, et al.. (1974). [Long term intestinal substitution in dogs].. PubMed. 28(9). 795–802. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cameron W. Lush Breakdown of academic impact, for papers by Micaela Bernareggi Breakdown of academic impact, for papers by Taku Tsunekawa Breakdown of academic impact, for papers by O. Wisén Breakdown of academic impact, for papers by Daniela Romualdi Breakdown of academic impact, for papers by Eva W. Iepsen Breakdown of academic impact, for papers by Adele Kennedy Breakdown of academic impact, for papers by Eugenio Arteaga Breakdown of academic impact, for papers by Petra Steindl Breakdown of academic impact, for papers by Jacob T. Mey
Rankless by CCL
2026